BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The stock traded as high as $1.80 and last traded at $1.50, with a volume of 79022 shares. The stock had previously closed at $1.56.
BioRestorative Therapies Stock Down 3.8 %
The stock has a 50-day moving average of $1.64 and a 200 day moving average of $1.58. The stock has a market cap of $2.46 billion, a PE ratio of -1.46 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- How to Calculate Return on Investment (ROI)
- Intel: Is Now the Time to Be Brave?Â
- Earnings Per Share Calculator: How to Calculate EPS
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Why Are These Companies Considered Blue Chips?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
